Search Results - "Di Mauro, M.G."

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer by Veronesi, U., Mariani, L., Decensi, A., Formelli, F., Camerini, T., Miceli, R., Di Mauro, M.G., Costa, A., Marubini, E., Sporn, M.B., De Palo, G.

“…Purpose: The synthetic retinoid fenretinide administered for 5 years for prevention of second breast cancer showed no difference after a median of 8 years, but…”
Get full text

Long-term tolerability of fenretinide (4-HPR) in breast cancer patients by Rotmensz, N, De Palo, G, Formelli, F, Costa, A, Marubini, E, Campa, T, Crippa, A, Danesini, G M, Delle Grottaglie, M, Di Mauro, M G

“…A group of 53 patients initially participating in a phase I trial with the synthetic retinoid fenretinide was assessed for the long-term tolerability of this…”
Get more information